MariMed (MRMD) Stock Price, News & Analysis

Company Overview

MariMed, Inc. is a U.S.-based cannabis company that develops, operates and manages licensed cannabis cultivation, processing and dispensary facilities. The company serves both medical and adult-use markets, where permitted by state law, and focuses on producing and distributing cannabis flower, concentrates, edibles, tinctures and other cannabis-infused products.

MariMed markets products under brands that have included Betty’s Eddies, Nature’s Heritage, InHouse and Kalm Fusion. Its products are sold through the company’s retail operations and third-party dispensaries in its operating markets. MariMed has also provided management and operational services to cannabis businesses, including support in cultivation, manufacturing, retail operations, compliance and brand development.

The company has operated in several state-regulated cannabis markets, including Massachusetts, Maryland, Delaware and Ohio. MariMed was established in 2011 and has expanded through the development and acquisition of cannabis businesses and licenses. Jon Levine serves as the company’s chief executive officer and chairman.

Key Stats

• Today's Range: $0.07 to $0.08
• 50-Day Range: $0.05 to $0.08
• 52-Week Range: $0.05 to $0.16
• Volume: 404,658 shs
• Average Volume: 943,478 shs
• Market Capitalization: $30.22 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

MariMed Stock Analysis - MarketRank™

MariMed scored higher than 13% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

MariMed has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

MariMed has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

MariMed has a P/B Ratio of 0.58. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of MariMed has been sold short.

Short Interest Ratio / Days to Cover

MariMed has a short interest ratio ("days to cover") of 0.02, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in MariMed has recently increased by 1,748.60%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

MariMed does not currently pay a dividend.

Dividend Growth

MariMed does not have a long track record of dividend growth.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.09

News Sentiment

MariMed has a news sentiment score of 0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for MariMed this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, MariMed insiders have not sold or bought any company stock.

Percentage Held by Insiders

16.05% of the stock of MariMed is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

0.18% of the stock of MariMed is held by institutions.

Company Calendar

• Last Earnings: 11/11/2026
• Today: 11/12/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MRMD
• Previous Symbol: OTC:MRMD
• CIK: 1522767
• Web: marimedinc.com
• Phone: (617) 795-5140
• Fax: N/A
• Employees: 866
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$14.48 million
• Net Margins: -9.27%
• Pretax Margin: -6.21%
• Return on Equity: -12.73%
• Return on Assets: -2.96%

Debt

• Debt-to-Equity Ratio: 1.78
• Current Ratio: 0.92
• Quick Ratio: 0.34

Sales & Book Value

• Annual Sales: $159.83 million
• Price / Sales: 0.19
• Cash Flow: $0.02 per share
• Price / Cash Flow: 3.22
• Book Value: $0.13 per share
• Price / Book: 0.58

Miscellaneous

• Outstanding Shares: 402,950,000
• Free Float: 338,281,000
• Market Cap: $30.22 million
• Optionable: Not Optionable
• Beta: 1.54